Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;157(1):42-50.
doi: 10.1002/ijgo.13747. Epub 2021 Jun 21.

A systematic review of biomarkers associated with maternal infection in pregnant and postpartum women

Affiliations

A systematic review of biomarkers associated with maternal infection in pregnant and postpartum women

Ayamo G Oben et al. Int J Gynaecol Obstet. 2022 Apr.

Abstract

Background: Serum biomarkers are commonly used to support the diagnosis of infection in non-pregnant patients whose clinical presentation suggests infection. The utility of serum biomarkers for infection in pregnant and postpartum women is uncertain.

Search strategy: PubMed, CINAHL, EMBASE, ClinicalTrials.gov, Cochrane Library, CINAHL, and SCOPUS were searched from inception to February 2020.

Selection criteria: Full-text manuscripts in English were included if they reported the measurement of maternal serum biomarkers-and included a control group-to identify infection in pregnant and postpartum women.

Data collection and analysis: two authors independently screened manuscripts, extracted data, and assessed methodologic quality.

Main results: Interleukin-6 (IL-6), C-reactive protein, procalcitonin, insulin-like growth factor binding protein 1, tumor necrosis factor-α, calgranulin B, neopterin, and interferon-γ inducible protein 10 reliably indicated infection. Intercellular adhesion molecule 1, monocyte chemotactic and activating factor, soluble IL-6 receptor, and IL-8 were not useful markers in pregnant and postpartum women.

Conclusions: Findings suggest that certain biomarkers have diagnostic value when maternal infection is suspected, but also confirms limitations in this population.

Keywords: biomarkers; chorioamnionitis; maternal morbidity; maternal mortality; puerperal infection; sepsis; systematic review.

PubMed Disclaimer

References

REFERENCES

    1. Petersen EE, Davis NL, Goodman D, et al. Vital signs: pregnancy-related deaths, United States, 2011-2015, and strategies for prevention, 13 states, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019;68(18):423-429.
    1. Seale AC. Recognising the burden of maternal infection worldwide. Lancet Glob Health. 2020;8(5):e615-e616.
    1. Woodd SL, Montoya A, Barreix M, et al. Incidence of maternal peripartum infection: a systematic review and meta-analysis. PLoS Medicine. 2019;16(12):e1002984.
    1. Bonet M. Frequency and management of maternal infection in health facilities in 52 countries (GLOSS): a 1-week inception cohort study. Lancet Glob Health. 2020;8(5):e661-e671.
    1. Finnegan LPSJ, Sanghvi H, Anker M. Infectious diseases and maternal morbidity and mortality. Emerg Infect Dis. 2004;10(11):e17.

Publication types

LinkOut - more resources